Gertrude Belle ELION
Biography

Gertrude B. Elion was a remarkable American biochemist and pharmacologist who made groundbreaking contributions to the field of medicine. Born on January 23, 1918, in New York City, she grew up in a time when opportunities for women in scientific fields were limited. Despite the challenges, Elion's passion for science and determination propelled her to break through gender barriers and leave an indelible mark on the world of medicine.

Elion's academic journey began at Hunter College in New York City, where she earned her Bachelor of Science degree in 1937. Initially interested in science, she faced difficulties finding a job in research due to her gender. Undeterred, she pursued a master's degree in chemistry from New York University and later worked as a lab assistant and high school teacher.

In 1944, Gertrude Elion joined the Burroughs Wellcome pharmaceutical company, where her career truly took off. She collaborated with George Hitchings, a fellow scientist, and together they embarked on a journey that would revolutionize the field of drug development. Elion and Hitchings pioneered a novel approach to drug discovery, focusing on understanding the biochemistry of cells and diseases before designing targeted medications.

One of their early breakthroughs was the development of 6-mercaptopurine, a drug that proved to be a game-changer in the treatment of leukemia. This marked the beginning of a series of innovations that would transform the landscape of medicine. Their work laid the foundation for rational drug design, a concept that involves developing drugs based on a deep understanding of the underlying biology of a disease.

In the following years, Elion and Hitchings continued their groundbreaking research, contributing to the development of drugs for various medical conditions, including malaria, autoimmune disorders, and organ transplant rejection. Their method of rational drug design was a revolutionary shift from the traditional trial-and-error approach, leading to more effective and targeted treatments.

In 1988, Gertrude Elion received the Nobel Prize in Physiology or Medicine, alongside George Hitchings and Sir James Black, for their significant contributions to drug development. Elion's award was particularly historic, as she became only the fifth woman to receive the Nobel Prize in Medicine.

Throughout her career, Gertrude Elion faced and overcame gender biases in the male-dominated field of science. She became a trailblazer for women in research, breaking down barriers and inspiring future generations of female scientists. Her work not only saved countless lives but also revolutionized the way pharmaceutical research is conducted.

Beyond her scientific achievements, Elion was known for her warmth, humility, and dedication to mentoring young scientists. She continued to work at Burroughs Wellcome (later GlaxoSmithKline) until her retirement in 1983. Even after retirement, she remained active in scientific and philanthropic endeavors.

Gertrude B. Elion passed away on February 21, 1999, leaving behind a legacy that continues to inspire scientists and researchers worldwide. Her contributions to medicine and her perseverance in the face of adversity serve as a testament to the power of passion, intellect, and determination in overcoming obstacles and making lasting contributions to humanity.



Learn more about the life of     Gertrude Belle ELION.

Visit Manhattan, New York, USA (New York City) (New Amsterdam) (Washington Heights)
Discover the people who lived there, the places they visited and the stories they shared.